Insulin glargine and lixisenatide Subcutaneous and Norethindrone and Mestranol
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Norethindrone and Mestranol and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: mestranol / norethindrone
Brand name: Necon 1/50, Norinyl 1+50
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Norethindrone Tablets
- Insulin glargine and lixisenatide Subcutaneous-Norethindrone, ethinyl estradiol, and ferrous fumarate
- Insulin glargine and lixisenatide Subcutaneous-Norflex
- Insulin glargine and lixisenatide Subcutaneous-Norflex Injection
- Insulin glargine and lixisenatide Subcutaneous-Norfloxacin
- Insulin glargine and lixisenatide Subcutaneous-Norgesic
- Norethindrone and Mestranol-Insulin glargine, recombinant Subcutaneous
- Norethindrone and Mestranol-Insulin glulisine
- Norethindrone and Mestranol-Insulin Glulisine (Cartridges and Pens)
- Norethindrone and Mestranol-Insulin Glulisine (Vials)
- Norethindrone and Mestranol-Insulin glulisine Subcutaneous
- Norethindrone and Mestranol-Insulin human inhaled Inhalation